CR
Charles Rhyee TD Cowen Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
1.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
61.5%
Neutral
38.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Industrials
Materials
Real Estate
Technology
Consumer Discretionary
Restaurants
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Industrials
Aerospace & Defense
Specialty Business Services
Materials
Agricultural Inputs
Real Estate
Diversified REIT
Technology
Communication Equipment
Semiconductors
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Upgraded
| $15 |
45%
upside
| 2 | -3.2% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Upgraded
| $213 |
21%
upside
| 2 | -5.4% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $300 |
79%
upside
| 1 | -19% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Hold
Maintained
| $6 |
5%
upside
| 1 | – |
–
| 26 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $235 |
28%
upside
| 1 | -4% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $9 |
74%
upside
| 1 | +6.4% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Buy
Upgraded
| $120 |
0%
upside
| 2 | +10% |
0
%
| 18 Feb ‘26 2 months ago |
|
|
|
Hold
Upgraded
| $419 |
20%
downside
| 1 | +1.7% |
0
%
| 18 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $338 |
21%
upside
| 1 | +2.6% |
0
%
| 9 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $1,012 |
17%
upside
| 1 | +13% |
0
%
| 5 Feb ‘26 2 months ago |
|